Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Swedberg

Showing results (131-140 of 471) with videos related to

Pageof 48
Sort By:
BMJ Open|September 3, 2020
Person-centred eHealth intervention for patients on sick leave due to common mental disorders: study protocol of a randomised controlled trial and process evaluation (PROMISE)Matilda Cederberg, Lilas Ali, Inger Ekman, et al.
Lancet (London, England)|August 31, 2010
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialMichael Böhm, Karl Swedberg, Michel Komajda, et al.
Circulation|August 21, 2002
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)Milton Packer, Robert M Califf, Marvin A Konstam, et al.
European Heart Journal|August 31, 2011
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudyJean-Claude Tardif, Eileen O'Meara, Michel Komajda, et al.
Lancet (London, England)|August 31, 2010
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyKarl Swedberg, Michel Komajda, Michael Böhm, et al.
Acute Cardiac Care|April 25, 2007
Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trialsLeonardo De Luca, Gregg C Fonarow, Alexandre Mebazaa, et al.
Journal of the American Heart Association|February 14, 2016
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) TrialMichael Böhm, Michele Robertson, Jeffrey Borer, et al.
European Journal of Heart Failure|June 26, 2014
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFTMichel Komajda, Michael Böhm, Jeffrey S Borer, et al.
JMIR Mental Health|March 15, 2022
Effects of a Person-Centered eHealth Intervention for Patients on Sick Leave Due to Common Mental Disorders (PROMISE Study): Open Randomized Controlled TrialMatilda Cederberg, Sara Alsén, Lilas Ali, et al.
European Journal of Heart Failure|March 31, 2025
Ivabradine improves win ratios of heart failure outcomes in patients with reduced ejection fraction - insights from the SHIFT trialAmr Abdin, Saarraaken Kulenthiran, Michel Komajda, et al.
Pageof 48

Showing results (131-140 of 471) with videos related to

Sort By:
Pageof 48
BMJ Open|September 3, 2020
Person-centred eHealth intervention for patients on sick leave due to common mental disorders: study protocol of a randomised controlled trial and process evaluation (PROMISE)Matilda Cederberg, Lilas Ali, Inger Ekman, et al.
Lancet (London, England)|August 31, 2010
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialMichael Böhm, Karl Swedberg, Michel Komajda, et al.
Circulation|August 21, 2002
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)Milton Packer, Robert M Califf, Marvin A Konstam, et al.
European Heart Journal|August 31, 2011
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudyJean-Claude Tardif, Eileen O'Meara, Michel Komajda, et al.
Lancet (London, England)|August 31, 2010
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyKarl Swedberg, Michel Komajda, Michael Böhm, et al.
Acute Cardiac Care|April 25, 2007
Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trialsLeonardo De Luca, Gregg C Fonarow, Alexandre Mebazaa, et al.
Journal of the American Heart Association|February 14, 2016
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) TrialMichael Böhm, Michele Robertson, Jeffrey Borer, et al.
European Journal of Heart Failure|June 26, 2014
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFTMichel Komajda, Michael Böhm, Jeffrey S Borer, et al.
JMIR Mental Health|March 15, 2022
Effects of a Person-Centered eHealth Intervention for Patients on Sick Leave Due to Common Mental Disorders (PROMISE Study): Open Randomized Controlled TrialMatilda Cederberg, Sara Alsén, Lilas Ali, et al.
European Journal of Heart Failure|March 31, 2025
Ivabradine improves win ratios of heart failure outcomes in patients with reduced ejection fraction - insights from the SHIFT trialAmr Abdin, Saarraaken Kulenthiran, Michel Komajda, et al.
Pageof 48